Santen Pharmaceutical Co., Ltd. (SNPHY)
R&D Expenses
¥26.48B
TTM · Period ending: · JPY

SNPHY R&D Expenses
What is r&d expenses?
Research and development spending.
SNPHY r&d expenses history
Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | R&D Expenses (JPY) | Change |
|---|---|---|
| 27,764,161,000 | +15.19% | |
| 24,103,000,000 | −5.17% | |
| 25,416,000,000 | −10.18% | |
| 28,297,000,000 | +7.28% | |
| 26,377,000,000 | +9.39% | |
| 24,112,000,000 | +3.30% | |
| 23,341,000,000 | −1.76% | |
| 23,759,000,000 | −2.62% | |
| 24,398,000,000 | +7.07% | |
| 22,786,000,000 | +13.99% | |
| 19,990,000,000 | +14.38% | |
| 17,477,000,000 | +3.65% | |
| 16,862,000,000 | +0.86% | |
| 16,719,000,000 | — | |
| 0 | — | |
| 0 | — | |
| 0 | — | |
| 0 | — | |
| 0 | — | |
| 0 | — | |
| 0 | — | |
| 0 | — |
Frequently asked questions: SNPHY r&d expenses
What is Santen Pharmaceutical Co., Ltd. (SNPHY)'s current r&d expenses?
Santen Pharmaceutical Co., Ltd. (SNPHY)'s latest reported r&d expenses (TTM) is ¥26.48B as of Sep 30, 2026. Research and development spending.
How much historical r&d expenses data is available for SNPHY?
Stock Alarm Pro provides 22 dated annual fiscal periods observations for Santen Pharmaceutical Co., Ltd. (SNPHY)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare SNPHY's r&d expenses to peers or set an alert?
You can open SNPHY's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on SNPHY delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance